HemoSonics, a medical device company, has been awarded a $525,000 grand prize in the NIH’s RADx Tech for Maternal Health Challenge. The company’s Quantra Hemostasis System, used for managing acute bleeding, shows promise for preventing postpartum hemorrhage, a leading cause of maternal mortality. This win highlights the potential of innovative diagnostics to improve maternal health outcomes and address global health disparities.